These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33941177)

  • 1. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
    Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
    PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessing medicines for non-communicable diseases: Patients and health care workers' experiences at public and private health facilities in Uganda.
    Tusubira AK; Akiteng AR; Nakirya BD; Nalwoga R; Ssinabulya I; Nalwadda CK; Schwartz JI
    PLoS One; 2020; 15(7):e0235696. PubMed ID: 32634164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.
    Rockers PC; Wirtz VJ; Vian T; Onyango MA; Ashigbie PG; Laing R
    BMJ Open; 2016 Nov; 6(11):e013386. PubMed ID: 27888177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya.
    Wirtz VJ; Turpin K; Laing RO; Mukiira CK; Rockers PC
    Trop Med Int Health; 2018 Aug; 23(8):879-885. PubMed ID: 29808960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties.
    Ashigbie PG; Rockers PC; Laing RO; Cabral HJ; Onyango MA; Buleti JPL; Wirtz VJ
    BMJ Open; 2020 May; 10(5):e035132. PubMed ID: 32414824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial.
    Rockers PC; Laing RO; Ashigbie PG; Onyango MA; Mukiira CK; Wirtz VJ
    Lancet Glob Health; 2019 Apr; 7(4):e492-e502. PubMed ID: 30799142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
    Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
    Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis.
    Kiragu ZW; Rockers PC; Onyango MA; Mungai J; Mboya J; Laing R; Wirtz VJ
    PLoS One; 2022; 17(4):e0266715. PubMed ID: 35443014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya.
    Rockers PC; Laing RO; Wirtz VJ
    BMJ Glob Health; 2018; 3(3):e000828. PubMed ID: 29989082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "These are just finishing our medicines": older persons' perceptions and experiences of access to healthcare in public and private health facilities in Uganda.
    Wandera SO; Golaz V; Kwagala B; Ntozi JPM; Ayuku DO
    BMC Health Serv Res; 2024 Mar; 24(1):396. PubMed ID: 38553700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
    Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
    BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts.
    Mukundiyukuri JP; Irakiza JJ; Nyirahabimana N; Ng'ang'a L; Park PH; Ngoga G; El-Khatib Z; Nditunze L; Dusengeyezu E; Rusangwa C; Mpunga T; Mubiligi J; Hedt-Gauthier B
    Ann Glob Health; 2020 Sep; 86(1):123. PubMed ID: 33024709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.
    Subramanian S; Gakunga R; Kibachio J; Gathecha G; Edwards P; Ogola E; Yonga G; Busakhala N; Munyoro E; Chakaya J; Ngugi N; Mwangi N; Von Rege D; Wangari LM; Wata D; Makori R; Mwangi J; Mwanda W;
    PLoS One; 2018; 13(1):e0190113. PubMed ID: 29304049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of medicines availability and stock-outs on household's utilization of healthcare services in Dodoma region, Tanzania.
    Kuwawenaruwa A; Wyss K; Wiedenmayer K; Metta E; Tediosi F
    Health Policy Plan; 2020 Apr; 35(3):323-333. PubMed ID: 31942625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to asthma medicines at the household level in eight counties of Kenya.
    Barakat D; Rockers PC; Vian T; Onyango MA; Laing RO; Wirtz VJ
    Int J Tuberc Lung Dis; 2018 May; 22(5):585-590. PubMed ID: 29663966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Views by health professionals on the responsiveness of commune health stations regarding non-communicable diseases in urban Hanoi, Vietnam: a qualitative study.
    Kien VD; Van Minh H; Giang KB; Ng N; Nguyen V; Tuan LT; Eriksson M
    BMC Health Serv Res; 2018 May; 18(1):392. PubMed ID: 29855320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.